Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kushwin Rajamani

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cardiology Clinics|May 6, 2014
Shock avoidance and the newer tachycardia therapy algorithmsKushwin Rajamani, Adam S Goldberg, Bruce L Wilkoff
Lancet (London, England)|May 26, 2009
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trialKushwin Rajamani, Peter G Colman, Li Ping Li, et al.
Diabetes Care|January 3, 2012
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD StudyRu-Dee Ting, Anthony C Keech, Paul L Drury, et al.
Diabetes|February 16, 2019
Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting ProteinJun Yuan, Joanne T M Tan, Kushwin Rajamani, et al.
Journal of Electrocardiology|May 4, 2020
Miniaturized implantable cardiac monitor with a long sensing vector (BIOMONITOR III): Insertion procedure assessment, sensing performance, and home monitoring transmission successJustin A Mariani, Rukshen Weerasooriya, Olivier van den Brink, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cardiology Clinics|May 6, 2014
Shock avoidance and the newer tachycardia therapy algorithmsKushwin Rajamani, Adam S Goldberg, Bruce L Wilkoff
Lancet (London, England)|May 26, 2009
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trialKushwin Rajamani, Peter G Colman, Li Ping Li, et al.
Diabetes Care|January 3, 2012
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD StudyRu-Dee Ting, Anthony C Keech, Paul L Drury, et al.
Diabetes|February 16, 2019
Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting ProteinJun Yuan, Joanne T M Tan, Kushwin Rajamani, et al.
Journal of Electrocardiology|May 4, 2020
Miniaturized implantable cardiac monitor with a long sensing vector (BIOMONITOR III): Insertion procedure assessment, sensing performance, and home monitoring transmission successJustin A Mariani, Rukshen Weerasooriya, Olivier van den Brink, et al.
Pageof 1